Bausch Health Companies Inc. (BHC) revenue
Bausch Health Companies Inc. (BHC) reported revenue of $10.27B in fiscal 2025 (the year ended December 31, 2025). That is 6.7% higher than the $9.63B of fiscal 2024. Figures as of 18 Nov 2026, 06:53 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Revenue, fiscal 2025
- $10.27B
- Change on fiscal 2024
- +6.7%
- Growth, 5 years
- +5.0% a year
- Growth, 10 years
- −0.2% a year
- Highest on record
- $10.45Bfiscal 2015
- Lowest on record
- $757.18Mfiscal 2008
- Fiscal years on record
- 182008–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Bausch Health Companies Inc. revenue, in more detail
Over the five fiscal years to 2025 revenue grew at a compound 5.0% a year; over ten years the rate was −0.2% a year. Across the 18 fiscal years on record (2008–2025), the highest was $10.45B in fiscal 2015 and the lowest $757.18M in fiscal 2008.
Revenue by fiscal year
Bausch Health Companies Inc. revenue, year by year
| Fiscal year | Revenue | Change | Year ended |
|---|---|---|---|
| 2025 | $10.27B | 6.7% up | |
| 2024 | $9.63B | 9.9% up | |
| 2023 | $8.76B | 7.8% up | |
| 2022 | $8.12B | 3.7% down | |
| 2021 | $8.43B | 5.1% up | |
| 2020 | $8.03B | 6.7% down | |
| 2019 | $8.60B | 2.6% up | |
| 2018 | $8.38B | 3.9% down | |
| 2017 | $8.72B | 9.8% down | |
| 2016 | $9.67B | 7.4% down | |
| 2015 | $10.45B | 27.3% up | |
| 2014 | $8.21B | 42.2% up | |
| 2013 | $5.77B | 65.8% up | |
| 2012 | $3.48B | 43.4% up | |
| 2011 | $2.43B | 105.5% up | |
| 2010 | $1.18B | 44.0% up | |
| 2009 | $820.43M | 8.4% up | |
| 2008 | $757.18M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
How to read it
Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.
Bausch Health Companies Inc., figure by figure
- Bausch Health Companies Inc. market cap
- Bausch Health Companies Inc. earnings
- Bausch Health Companies Inc. earnings per share (EPS)
- Bausch Health Companies Inc. P/E ratio
- Bausch Health Companies Inc. P/S ratio
- Bausch Health Companies Inc. P/B ratio
- Bausch Health Companies Inc. free cash flow
- Bausch Health Companies Inc. operating margin
- Bausch Health Companies Inc. dividend
- Bausch Health Companies Inc. shares outstanding
- Bausch Health Companies Inc. total debt
- Bausch Health Companies Inc. cash on hand
- Bausch Health Companies Inc. total assets
- Bausch Health Companies Inc. return on equity (ROE)
- Bausch Health Companies Inc. return on invested capital (ROIC)
Bausch Health Companies Inc. (BHC) overview: price, valuation and scorecard
Bausch Health Companies Inc. revenue: questions and answers
What is Bausch Health Companies Inc.'s revenue?
Bausch Health Companies Inc. (BHC) reported revenue of $10.27B in fiscal 2025 (the year ended December 31, 2025). That is 6.7% higher than the $9.63B of fiscal 2024.
What is the growth rate of Bausch Health Companies Inc.'s revenue?
Over the five fiscal years to 2025 revenue grew at a compound 5.0% a year; over ten years the rate was −0.2% a year.
What are the highest and lowest revenue figures on record for Bausch Health Companies Inc.?
Across the 18 fiscal years on record (2008–2025), the highest was $10.45B in fiscal 2015 and the lowest $757.18M in fiscal 2008.
How is Bausch Health Companies Inc.'s revenue calculated?
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
Fiscal years are named for the calendar year they end in.
Learn: revenue
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Bausch Health Companies Inc. (BHC) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/BHC/revenue
Underlying data: the company's filings with the SEC and Yahoo Finance.